HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies

HIV-associated exosomes promote infection of Kaposi sarcoma-associated herpesvirus via epidermal growth factor receptor

(2020) Lechuang Chen et al.   JOURNAL OF VIROLOGY

Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

(2020) Julia Bergild McBrien et al.   NATURE

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

(2020) Christopher C. Nixon et al.   NATURE

Faible indice de masse corporelle et impact des antirétroviraux sur la néphrotoxicité, la maladie rénale chronique chez les patients infectés par le VIH à Brazzaville, Congo

(2020) Martin Herbas Ekat et al.   Nephrologie & Therapeutique

The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice

(2020) Michael Bobardt et al.   PLoS One

Barriers to kidney transplant evaluation in HIV‐positive patients with advanced kidney disease: A single‐center study

(2020) Suzanne M. Boyle et al.   Transplant Infectious Disease

Chronic lung disease in children and adolescents with HIV: a case–control study

(2020) Grace McHugh et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Sensing of HIV-1 by TLR8 activates human T cells and reverses latency

(2020) Hany Zekaria Meås et al.   Nature Communications

Differences in Transcriptional Dynamics Between T-cells and Macrophages as Determined by a Three-State Mathematical Model

(2020) Catherine DeMarino et al.   Scientific Reports

Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence

(2020) Leo Swadling et al.   Cell Reports

Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection

(2020) Ibolya E. András et al.   Molecular Brain

Diverse effects of interferon alpha on the establishment and reversal of HIV latency

(2020) Renée M. Van der Sluis et al.   PLoS Pathogens

Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women

(2020) Mark D. Pankau et al.   PLoS Pathogens

Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy

(2020) Catalina Barceló et al.   Open Forum Infectious Diseases

Alterations of redox and iron metabolism accompany the development of HIV latency

(2020) Iart Luca Shytaj et al.   EMBO JOURNAL

Targeting Inflammation Driven by HMGB1

(2020) Huan Yang et al.   Frontiers in Immunology

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies

(2020) Shunling Yuan et al.   Journal of Hematology & Oncology

Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor

(2020) Alice Fletcher-Etherington et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway

(2020) Robert A. Barclay et al.   Viruses-Basel

HIV infects astrocytes in vivo and egresses from the brain to the periphery

(2020) Victoria Lutgen et al.   PLoS Pathogens

Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections

(2020) Sushant Khanal et al.   JOURNAL OF VIROLOGY

Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals

(2020) Gavin C. Sampey et al.   Viruses-Basel

Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway

(2019) Thijs van Montfort et al.   EBioMedicine

Reduction of HIV-1 Reservoir Size and Diversity After 1 Year of cART Among Brazilian Individuals Starting Treatment During Early Stages of Acute Infection

(2019) Thaysse Ferreira Leite et al.   Frontiers in Microbiology

HUSH, a Link Between Intrinsic Immunity and HIV Latency

(2019) Ghina Chougui et al.   Frontiers in Microbiology

How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication

(2019) Wolfgang Eisenreich et al.   Frontiers in Cellular and Infection Microbiology

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals

(2019) Rémi Fromentin et al.   Nature Communications

Entry of Polarized Effector Cells into Quiescence Forces HIV Latency

(2019) Curtis Dobrowolski et al.   mBio

Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages

(2019) Shringar Rao et al.   Retrovirology

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate

(2019) Michael Bobardt et al.   PLoS One

Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy

(2019) Kevin B. Einkauf et al.   JOURNAL OF CLINICAL INVESTIGATION

The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study

(2019) Ling Luo et al.   BMC INFECTIOUS DISEASES

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments

(2019) Anna Kula et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Selective cell death of latently HIV-infected CD4+ T cells mediated by autosis inducing nanopeptides

(2019) Gang Zhang et al.   Cell Death & Disease

Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat

(2019) Chuan Li et al.   Epigenetics & Chromatin

Transcriptional Circuit Fragility Influences HIV Proviral Fate

(2019) Emily L. Morton et al.   Cell Reports

Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1

(2019) Jan Kristoff et al.   EBioMedicine

Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy

(2019) Jing Shen et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Viral hijacking of cellular metabolism

(2019) Shivani K. Thaker et al.   BMC BIOLOGY

NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology

(2019) Xiaolong He et al.   Cellular & Molecular Immunology

Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs

(2019) Ivan Sadowski et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion

(2019) Omar Khan et al.   NATURE

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

(2019) Smita Kulkarni et al.   NATURE IMMUNOLOGY

TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion

(2019) Hyungseok Seo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

(2019) Prasanta K. Dash et al.   Nature Communications

Topological DNA damage, telomere attrition and T cell senescence during chronic viral infections

(2019) Yingjie Ji et al.   Immunity & Ageing

Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions

(2019) Dechao Cao et al.   Frontiers in Immunology

Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection

(2019) Edurne Garcia-Vidal et al.   ANTIVIRAL RESEARCH

Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial

(2019) Ricardo Sobhie Diaz et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas

(2019) Vibudh Agrawal et al.   MOLECULES

Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations

(2019) Judith Grau-Expósito et al.   PLoS Pathogens

Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations

(2019) Mabel Toribio et al.   Current HIV/AIDS Reports

Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models

(2019) María Rosa López-Huertas et al.   Molecular Therapy-Nucleic Acids

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

(2019) Gilles Darcis et al.   Frontiers in Immunology

The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence

(2019) Aswath P. Chandrasekar et al.   CLINICAL MICROBIOLOGY REVIEWS

The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

(2019) Melissa-Rose Abrahams et al.   Science Translational Medicine

TREM-1 Protects HIV-1-Infected Macrophages from Apoptosis through Maintenance of Mitochondrial Function

(2019) Grant R. Campbell et al.   mBio

Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab

(2019) Carla Serra-Peinado et al.   Nature Communications

A broad drug arsenal to attack a strenuous latent HIV reservoir

(2019) Mateusz Stoszko et al.   Current Opinion in Virology

ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy

(2019) Juan Zhao et al.   Frontiers in Immunology

Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy

(2019) Lisa J. Henderson et al.   AIDS

Mitochondrial DNA Haplogroups and Frailty in Adults Living with HIV

(2019) Kristine M. Erlandson et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV

(2018) Youry Kim et al.   Cell Host & Microbe

Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4 + T Cells

(2018) Hsiao-Hsuan Kuo et al.   IMMUNITY

Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation

(2018) Uri Mbonye et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed

(2018) Simin D. Rezaei et al.   JOURNAL OF VIROLOGY

CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals

(2018) Alessandra Noto et al.   JOURNAL OF VIROLOGY

Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression

(2018) Chen Huan et al.   JOURNAL OF VIROLOGY

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells

(2018) Mohamed Abdel-Mohsen et al.   Science Translational Medicine

Recent progress in understanding HIV reservoirs

(2018) Hsiao-Hsuan Kuo et al.   Current Opinion in HIV and AIDS

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells

(2018) Catherine DeMarino et al.   Scientific Reports

HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction

(2018) Siobhan Gargan et al.   EBioMedicine

CD4+ memory T cells infected with latent HIV-1 are susceptible to drugs targeting telomeres

(2018) Dorota Piekna-Przybylska et al.   CELL CYCLE

Telomere length and telomerase activity in T cells are biomarkers of high-performing centenarians

(2018) Enzo Tedone et al.   AGING CELL

Inhibitors of Signaling Pathways that Block Reversal of HIV-1 Latency

(2018) Benni Vargas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection

(2018) José Carlos Valle-Casuso et al.   Cell Metabolism

Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal

(2018) Kouki Matsuda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1

(2018) Daniele C. Cary et al.   PLoS One

Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA

(2018) Lechuang Chen et al.   Nature Communications

Defining control of HIV epidemics

(2018) Alison P Galvani et al.   Lancet HIV

Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells From HIV-Infected Patients

(2017) Fengting Yu et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion

(2017) Alejandro Gonzalez-Serna et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Exosomes from uninfected cells activate transcription of latent HIV-1

(2017) Robert A. Barclay et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target

(2017) Sonya VanPatten et al.   JOURNAL OF MEDICINAL CHEMISTRY

JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1

(2017) Yudong Quan et al.   JOURNAL OF VIROLOGY

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

(2017) Benjamin Descours et al.   NATURE

HIV integration sites in latently infected cell lines: evidence of ongoing replication

(2017) Jori Symons et al.   Retrovirology

Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective

(2017) Sarah Chwiki et al.   ULTRASTRUCTURAL PATHOLOGY

TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia

(2017) Riadh Lobbardi et al.   Cancer Discovery

Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation

(2017) Alberto Bosque et al.   Cell Reports

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

(2017) Christina Gavegnano et al.   PLoS Pathogens

The Molecular Basis for Human Immunodeficiency Virus Latency

(2017) Uri Mbonye et al.   Annual Review of Virology

The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders

(2017) Annette J. Theron et al.   Frontiers in Immunology

HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus

(2017) S. Chinnapaiyan et al.   PLoS One

Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine

(2017) Liqun Liu et al.   Scientific Reports

Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus

(2016) Laura J. Martins et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

The mTOR Complex Controls HIV Latency

(2016) Emilie Besnard et al.   Cell Host & Microbe

Mechanisms of ferroptosis

(2016) Jennifer Yinuo Cao et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Modulation of apoptosis and viral latency – an axis to be well understood for successful cure of human immunodeficiency virus

(2016) Uddhav Timilsina et al.   JOURNAL OF GENERAL VIROLOGY

International AIDS Society global scientific strategy: towards an HIV cure 2016

(2016) Steven G Deeks et al.   NATURE MEDICINE

PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals

(2016) Riddhima Banga et al.   NATURE MEDICINE

HIV integration and the establishment of latency in CCL19-treated resting CD4+ T cells require activation of NF-κB

(2016) Suha Saleh et al.   Retrovirology

Tissue reservoirs of HIV

(2016) Joseph K. Wong et al.   Current Opinion in HIV and AIDS

Establishment and stability of the latent HIV-1 DNA reservoir

(2016) Johanna Brodin et al.   eLife

HIV-1 Integration Landscape during Latent and Active Infection

(2015) Lillian B. Cohn et al.   CELL

Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1–Infected Patients Treated With Combined Antiretroviral Therapy

(2015) José-Ramón Blanco et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA

(2015) Gavin C. Sampey et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MD-2 is required for disulfide HMGB1–dependent TLR4 signaling

(2015) Huan Yang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

SP269ANTIRETROVIRAL THERAPY-RELATED NEPHROTOXICITY IN HIV INFECTED PATIENTS WITH LOW BODY MASS INDEX OUTPATIENT FOLLOW-UP IN BRAZZAVILLE, CONGO

(2015) Martin Herbas Ekat et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2

(2015) Roland N. Wagner et al.   Retrovirology

Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch

(2015) Narasimhan J. Venkatachari et al.   Retrovirology

How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?

(2015) Jintanat Ananworanich et al.   Current Opinion in HIV and AIDS

Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus ReactivationIn Vitro

(2014) Christina Gavegnano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

TOX2 regulates human natural killer cell development by controlling T-BET expression

(2014) Q. P. Vong et al.   BLOOD

Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells

(2014) Ying Yang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Delayed-type hypersensitivity and hepatitis B vaccine responses, in vivo markers of cellular and humoral immune function, and the risk of AIDS or death

(2014) Shane B. Patterson et al.   VACCINE

Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines

(2014) Yudong Quan et al.   Virology Journal

Defining NELF-E RNA Binding in HIV-1 and Promoter-Proximal Pause Regions

(2014) John M. Pagano et al.   PLoS Genetics

Accelerated biological ageing in HIV-infected individuals in South Africa

(2013) Sophia Pathai et al.   AIDS

Exosomes Derived from HIV-1-infected Cells Contain Trans-activation Response Element RNA

(2013) Aarthi Narayanan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Kinase Control of Latent HIV-1 Infection: PIM-1 Kinase as a Major Contributor to HIV-1 Reactivation

(2013) A. Duverger et al.   JOURNAL OF VIROLOGY

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

(2013) Gilad Doitsh et al.   NATURE

Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV

(2013) Jonathan K. Chan et al.   PLoS One

TOX4 and NOVA1 Proteins Are Partners of the LEDGF PWWP Domain and Affect HIV-1 Replication

(2013) Mehdi Morchikh et al.   PLoS One

HIV Latency

(2013) R. F. Siliciano et al.   Cold Spring Harbor Perspectives in Medicine

Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients Reveals that the Majority of CD4+ T-cells Contain One HIV-1 DNA Molecule

(2013) Lina Josefsson et al.   PLoS Pathogens

JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease

(2012) John J. O'Shea et al.   IMMUNITY

Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production

(2012) Matthieu Perreau et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cyclin T1 and CDK9 T-Loop Phosphorylation Are Downregulated during Establishment of HIV-1 Latency in Primary Resting Memory CD4+ T Cells

(2012) S. Budhiraja et al.   JOURNAL OF VIROLOGY

Unknown

(2012) Mudit Tyagi et al.   MOLECULAR MEDICINE

Dynamic Ensemble View of the Conformational Landscape of HIV-1 TAR RNA and Allosteric Recognition

(2011) Jia Lu et al.   BIOCHEMISTRY

HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells

(2011) M-L Gougeon et al.   CELL DEATH AND DIFFERENTIATION

Negative Regulation of HIV-1 Transcription by a Heterodimeric NF-κB1/p50 and C-Terminally Truncated STAT5 Complex

(2011) Giulia Della Chiara et al.   JOURNAL OF MOLECULAR BIOLOGY

mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling

(2011) V. S. Rodrik-Outmezguine et al.   Cancer Discovery

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

(2010) Tae-Wook Chun et al.   AIDS

TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs

(2010) Christophe Bounaix Morand du Puch et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors

(2010) Qing-Bai She et al.   CANCER CELL

TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitro

(2010) Sohyun Yun et al.   IMMUNOLOGY LETTERS

TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex

(2010) S. Dittmer et al.   JOURNAL OF CELL SCIENCE

Increased Regulatory T Cell Counts in HIV‐Infected Nonresponders to Hepatitis B Virus Vaccine

(2010) María del Mar del Pozo Balado et al.   JOURNAL OF INFECTIOUS DISEASES

Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton

(2010) P. U. Cameron et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HIV integration site distributions in resting and activated CD4+ T cells infected in culture

(2009) Troy Brady et al.   AIDS

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies

(2009) Laurence Colin et al.   Retrovirology

Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells

(2008) A. Bosque et al.   BLOOD

Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency

(2008) Tina Lenasi et al.   Cell Host & Microbe

Development of all CD4 T lineages requires nuclear factor TOX

(2008) Parinaz Aliahmad et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy

(2008) Pauline Chugh et al.   Retrovirology